Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibitionRachele Niccolai(The Netherlands Cancer Institute), Heinz Jacobs(Dutch Cancer Society)NeoplasiaOctober 27, 202510.1016/j.neo.2025.101243Cited by 0SaveCiteExport RISWatch citationsRelated PapersDivision of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicine|Nucleic Acids Research|2022|28